Abbvie Inc (NYSE:ABBV) currently has a daily average trading volume of 8.11M but it saw 4689223 shares traded in last market. With a market cap of 322.44B USD, the company’s current market price of $182.54 came rising about 0.41 while comparing to the previous closing price of $181.80. In past 52 weeks, the stock remained buoying in the range of price level as high as $218.66 and as low as $153.58.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Citigroup which downgraded the stock as “Neutral” in its note to investors issued on May 14, 2025, recommending a price target of $205 for it. BofA Securities issued its recommendations for the stock as it resumed the price target for the stock is $191.
Over the week, ABBV’s stock price is moving 0.47% up while it is 3.10% when we observe its performance for the past one month. Year-to-date it is 2.72% up and over the past year, the stock is showing an upside performance of 10.93%.
Currently, Abbvie Inc’s total number of outstanding shares is 1.77B with 0.10% of that held by the insiders while 74.54% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 6.30% and return on equity (ROE) at 88.15%. It has a price to earnings ratio (P/E ratio) of 77.84 while having a 13.05 of forward P/E ratio. Stock’s beta reads 0.50. Stock has a price to book (P/B) ratio of 227.05 while price to sale or P/S ratio amounts to 5.62. Its return on asset (ROA) is 2.92% on average.
